Cargando…
Immune oncology, immune responsiveness and the theory of everything
Anti-cancer immunotherapy is encountering its own checkpoint. Responses are dramatic and long lasting but occur in a subset of tumors and are largely dependent upon the pre-existing immune contexture of individual cancers. Available data suggest that three landscapes best define the cancer microenvi...
Autores principales: | Turan, Tolga, Kannan, Deepti, Patel, Maulik, Matthew Barnes, J., Tanlimco, Sonia G., Lu, Rongze, Halliwill, Kyle, Kongpachith, Sarah, Kline, Douglas E., Hendrickx, Wouter, Cesano, Alessandra, Butterfield, Lisa H., Kaufman, Howard L., Hudson, Thomas J., Bedognetti, Davide, Marincola, Francesco, Samayoa, Josue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989400/ https://www.ncbi.nlm.nih.gov/pubmed/29871670 http://dx.doi.org/10.1186/s40425-018-0355-5 |
Ejemplares similares
-
A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival
por: Turan, Tolga, et al.
Publicado: (2020) -
Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival
por: Turan, Tolga, et al.
Publicado: (2020) -
Cancer immune resistance: can theories converge?
por: Lu, Rongze, et al.
Publicado: (2017) -
iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration
por: Turan, Tolga, et al.
Publicado: (2023) -
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
por: Danaher, Patrick, et al.
Publicado: (2018)